D. Brent

发表

A comprehensive method for determining hydrophobicity constants by reversed-phase high-performance liquid chromatography.

M. A. Patrick, J. Frenz, D. Minick, 1988, Journal of medicinal chemistry.

A simplified high-pressure liquid chromatography method for determining lipophilicity for structure-activity relationships.

D. Henry, D. Minick, D. Brent, 1983, Journal of medicinal chemistry.

Field desorption mass spectrometry of azathioprine and its metabolites.

H. Schulten, D. Brent, P. D. de Miranda, 1974, Journal of pharmaceutical sciences.

Chemical identification of a tumor-derived angiogenic factor.

P. Cuatrecasas, D. Brent, I. Parikh, 1987, Science.

Identification of progesterone and cortisol as immunoreactive plasma digitalis like factors in pregnancy.

M. H. Gault, S. Vasdev, L. Longerich, 1988, Research communications in chemical pathology and pharmacology.

Ligand Binding

M. S. Milella, Helen E. Gibson, R. Cools, 2020, Definitions.

Field desorption mass spectrometry quaternary ammonium salts

M. M. Bursey, D. Brent, D. Rouse, 1973 .

Derivatization to improve thermospray HPLC/MS sensitivity for the determination of prostaglandins and thromboxane B2.

D. Brent, R. Voyksner, E. Bush, 1987, Biomedical & environmental mass spectrometry.

Quantitative Structure-Activity Relationships Using Hydrophobicity Constants Measured by High-Pressure Liquid Chromatography: A Comparison with Octanol-Water Partition Coefficients

D. Minick, D. Brent, J. Sabatka, 1987 .

Cleaning of mass spectrometer ion sources by electropolishing

D. Brent, G. Peele, 1977 .

Field desorption mass spectrometry of ten medicinal carbamates.

D. Brent, D. Rouse, 1974, Biomedical mass spectrometry.

Use of a time averaging computer for high resolution field desorption mass spectrometry.

D. Brent, G. Peele, 1978, Biomedical mass spectrometry.

Rearrangement of chloramphenicol-3-monosuccinate.

D. Brent, J. T. Burke, A. Ragouzeos, 1980, Journal of pharmaceutical sciences.

Antitumor agents XLV: Bisbrusatolyl and brusatolyl esters and related compounds as novel potent antileukemic agents.

K. Lee, I. Hall, D. Brent, 1982, Journal of pharmaceutical sciences.

Isolation of a specific mu-opiate receptor peptide, morphiceptin, from an enzymatic digest of milk proteins.

D. Brent, J. K. Chang, K. Chang, 1985, The Journal of biological chemistry.

Digitalis-like factors in plasma of healthy human adults

M. H. Gault, S. Vasdev, L. Longerich, 1986 .

The use of mass spectrometric data to predict biological activity.

D. Brent, T. R. Brunner, B. Roth, 1981, Biomedical mass spectrometry.

Dehydroepiandrosterone sulfate as a digitalis like factor in plasma of healthy human adults.

M. H. Gault, S. Vasdev, L. Longerich, 1985, Research communications in chemical pathology and pharmacology.

Morphine in cow and human milk: could dietary morphine constitute a ligand for specific morphine (mu) receptors?

P. Cuatrecasas, D. Brent, E. Hazum, 1981, Science.

A SIMPLIFIED HIGH-PRESSURE LIQUID CHROMATOGRAPHY METHOD FOR DETERMINING LIPOPHILICITY FOR STRUCTURE-ACTIVITY RELATIONSHIPS

D. Henry, D. Minick, D. Brent, 1983 .

Plasma conjugated androgens in a dialysis-dependent male as immunoreactive digitalis-like factors.

M. H. Gault, L. Longerich, D. Brent, 1990, Clinical Nephrology.

Ligand Binding

M. S. Milella, Helen E. Gibson, R. Cools, 2020, Definitions.

Mass Spectra and Pyrolyses of o-Phenylene Carbonate and Related Compounds

D. Brent, D. Dejongh, 1970 .

Modeling octanol—water partition coefficients by reversed-phase liquid chromatography

J. Frenz, D. Minick, D. Brent, 1989 .

Field desorption mass spectrometry of the B vitamins: pyridoxal, pyridoxamine, their phosphates, and thiamine.

D. Brent, M. C. Sammons, M. Bursey, 1974, Biomedical mass spectrometry.

Metabolism and disposition of carbon 14 labeled bupropion in rats

D. H. Schroeder, P. G. Smith, R. Welch, 1980 .

Measurement of lipophilicity by high performance liquid chromatography comparison with calculated lipophilicity values

D. Minick, D. Brent, J. Sabatka, 1987 .